Innovation projects


Lupcon

PI: Karen Kristine Sørensen

The project aims to develop a method to control liver uptake that will increase the effectiveness of large-molecule drugs and nanoformulations in the treatment of patients.

Partners:

  • Norinnova 
  • SINTEF 

Financing: NFR /NRC Commercialisation Project Verification

 VBRG members:

  

interNASH

PI: Gahl Levy

An intercellular-pathway therapeutic for non-alcoholic steatohepatitis. The project aims to develop new methods and approaches to treat NASH 

Financing: NFR/NRC Commercialisation Project Qualification

 VBRG members:

   

NANO-BLOCK

PI: Karolina Szafranska

The main obstacle preventing nanomedicine advancement is unwanted uptake by the liver. This project focuses on repurposing medications to block unwanted liver-mediated nanomedicine uptake.

Partners:

  • SINTEF
  • Norinnova

Financing: UiT Innovation funding 

VBRG members: